新兴市场美元债-iShares EMB 深 沪
等待开盘 08-27 09:30:00 美东时间
93.82
-0.020
-0.02%
华盛通- 最 高93.83
- 今 开93.75
- 成交量 615.81万股
- 最 低 93.60
- 昨 收 93.84
- 总市值 135.10亿
- 52周最高 94.27
- 市盈率 静 --
- 换手率 4.28%
- 52周最低 83.1814
- 委 比 25.72%
- 总股本 1.44亿
- 历史最高 95.6769
- 量 比 0.93
- 振 幅 0.25%
- 历史最低 52.6844
- 每 手 1
- 风险率 2.00%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多EpicQuest Education Announces First Half Fiscal Year 2025 Financial Results
Revenue Rises a Robust 29% from the Year-Ago Period Driven by International Programs MIDDLETOWN, Ohio, Aug. 21, 2025 /PRNewswire/ -- EpicQuest Education Group International Limited (NASDAQ: ...
08-22 05:00
RxSight, Inc. (RXST) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
LOS ANGELES, Aug. 14, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to RxSight, Inc. ("RxSight" or the "Company") (NASDAQ: RXST) have opp...
08-15 00:00
embecta Announces Quarterly Cash Dividend
Embecta Corp announced a $0.15 per share quarterly dividend, payable on September 15, 2025, to shareholders of record as of August 29, 2025. The company, a global leader in insulin delivery, is expanding into broader medical supplies to enhance lives through innovation and partnerships.
08-08 10:00
美股ETF日报 | “AI应用”大牛股Applovin绩后大涨近12%！两倍做多APP ETF单日飙涨21%
“AI应用”大牛股Applovin绩后大涨近12%！两倍做多APP ETF单日飙涨21%；大行唱多CoreWeave下周季报强劲，CWVX隔夜大涨逾18%>>
08-08 17:00
Cybin's Clinical Trial Application Approved By Irish Medicines Board To Initiate EMBRACE Study In Ireland, Poland, And Greece
- EMBRACE, the second study within the Phase 3 PARADIGM program, will enroll 330 participants at approximately 60 clinical sites across the United States, Europe, the United Kingdom, and Australia -- European CTA
08-07 19:42
美股ETF日报 | 绩后连续大涨！两倍做多Reddit ETF再升14%；做多RGTI杠杆ETF飙涨23%
Reddit绩后连续大涨！两倍做多Reddit ETF再升14%；量子计算概念热度不减，两倍做多RGTI杠杆ETF单日飙涨23%>>
08-05 17:07
Biohaven Ltd. (BHVN) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
LOS ANGELES, July 28, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Biohaven Ltd. ("Biohaven" or the "Company") (NYSE: BHVN) have oppo...
07-29 00:00
Ardagh Group S.A. Announces Comprehensive Recapitalization Transaction
Supported by Overwhelming Majority of Financial Stakeholders Significantly Lowers Debt, Extends Next Bond Maturity to 2030 and Injects New Capital Glass and Metal Packaging Businesses to R...
07-28 16:45
Ardagh Metal Packaging S.A. Declares Quarterly Interim Dividend
LUXEMBOURG, July 24, 2025 /PRNewswire/ -- Ardagh Metal Packaging S.A. (NYSE: AMBP) announces that its board of directors has approved a quarterly interim dividend of $0.10 per ordinary share...
07-24 19:00
阿拉斯加航空公司因IT系统故障停飞所有航班
美国航空公司阿拉斯加航空当地时间周日遭遇IT故障，系统受到影响，该公司表示停飞所有航班，但没有说明故障的性质。“太平洋时间周日晚上8点左右（北京时间周一上午...
07-21 12:53
公司简介
公司名称
|
iShares JP Morgan USD Emerging Markets Bond ETF
|
行业分类
|
Investment Trusts/Mutual Funds
|
业务描述
|
Exists as exchange Traded Fund
|
EpicQuest Education Announces First Half Fiscal Year 2025 Financial Results
Revenue Rises a Robust 29% from the Year-Ago Period Driven by International Programs MIDDLETOWN, Ohio, Aug. 21, 2025 /PRNewswire/ -- EpicQuest Education Group International Limited (NASDAQ: ...
08-22 05:00
RxSight, Inc. (RXST) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
LOS ANGELES, Aug. 14, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to RxSight, Inc. ("RxSight" or the "Company") (NASDAQ: RXST) have opp...
08-15 00:00
embecta Announces Quarterly Cash Dividend
Embecta Corp announced a $0.15 per share quarterly dividend, payable on September 15, 2025, to shareholders of record as of August 29, 2025. The company, a global leader in insulin delivery, is expanding into broader medical supplies to enhance lives through innovation and partnerships.
08-08 10:00
美股ETF日报 | “AI应用”大牛股Applovin绩后大涨近12%！两倍做多APP ETF单日飙涨21%
“AI应用”大牛股Applovin绩后大涨近12%！两倍做多APP ETF单日飙涨21%；大行唱多CoreWeave下周季报强劲，CWVX隔夜大涨逾18%>>
08-08 17:00
Cybin's Clinical Trial Application Approved By Irish Medicines Board To Initiate EMBRACE Study In Ireland, Poland, And Greece
- EMBRACE, the second study within the Phase 3 PARADIGM program, will enroll 330 participants at approximately 60 clinical sites across the United States, Europe, the United Kingdom, and Australia -- European CTA
08-07 19:42
美股ETF日报 | 绩后连续大涨！两倍做多Reddit ETF再升14%；做多RGTI杠杆ETF飙涨23%
Reddit绩后连续大涨！两倍做多Reddit ETF再升14%；量子计算概念热度不减，两倍做多RGTI杠杆ETF单日飙涨23%>>
08-05 17:07
Biohaven Ltd. (BHVN) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
LOS ANGELES, July 28, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Biohaven Ltd. ("Biohaven" or the "Company") (NYSE: BHVN) have oppo...
07-29 00:00
Ardagh Group S.A. Announces Comprehensive Recapitalization Transaction
Supported by Overwhelming Majority of Financial Stakeholders Significantly Lowers Debt, Extends Next Bond Maturity to 2030 and Injects New Capital Glass and Metal Packaging Businesses to R...
07-28 16:45
Ardagh Metal Packaging S.A. Declares Quarterly Interim Dividend
LUXEMBOURG, July 24, 2025 /PRNewswire/ -- Ardagh Metal Packaging S.A. (NYSE: AMBP) announces that its board of directors has approved a quarterly interim dividend of $0.10 per ordinary share...
07-24 19:00
阿拉斯加航空公司因IT系统故障停飞所有航班
美国航空公司阿拉斯加航空当地时间周日遭遇IT故障，系统受到影响，该公司表示停飞所有航班，但没有说明故障的性质。“太平洋时间周日晚上8点左右（北京时间周一上午...
07-21 12:53
年度
|
派息内容
| 派息日期 |
0.41
|
2025-08-06
| |
0.38
|
2025-07-07
| |
0.41
|
2025-06-05
| |
0.40
|
2025-05-06
| |
0.40
|
2025-04-04
| |
0.39
|
2025-03-06
| |
0.44
|
2025-02-06
| |
0.25
|
2025-01-03
| |
0.43
|
2024-12-23
| |
0.39
|
2024-12-05
| |
0.42
|
2024-11-06
| |
0.39
|
2024-10-04
| |
0.37
|
2024-09-06
| |
0.39
|
2024-08-06
| |
0.38
|
2024-07-05
| |
0.36
|
2024-06-07
| |
0.36
|
2024-05-07
| |
0.37
|
2024-04-05
| |
0.39
|
2024-03-07
| |
0.37
|
2024-02-07
| |
0.36
|
2023-12-20
| |
0.33
|
2023-12-07
| |
0.36
|
2023-11-07
| |
0.35
|
2023-10-06
| |
0.36
|
2023-09-08
| |
0.35
|
2023-08-07
| |
0.35
|
2023-07-10
| |
0.35
|
2023-06-07
| |
0.35
|
2023-05-05
| |
0.36
|
2023-04-07
| |
0.38
|
2023-03-07
| |
0.31
|
2023-02-07
| |
0.34
|
2022-12-21
| |
0.34
|
2022-12-07
| |
0.38
|
2022-11-07
| |
0.37
|
2022-10-07
| |
0.31
|
2022-09-08
| |
0.35
|
2022-08-05
| |
0.36
|
2022-07-08
| |
0.33
|
2022-06-07
| |
0.36
|
2022-05-06
| |
0.38
|
2022-04-07
| |
0.36
|
2022-03-07
| |
0.37
|
2022-02-07
| |
0.37
|
2021-12-22
| |
0.36
|
2021-12-07
| |
0.36
|
2021-11-05
| |
0.35
|
2021-10-07
| |
0.35
|
2021-09-08
| |
0.35
|
2021-08-06
| |
0.36
|
2021-07-08
| |
0.36
|
2021-06-07
| |
0.35
|
2021-05-07
| |
0.35
|
2021-04-08
| |
0.35
|
2021-03-05
| |
0.36
|
2021-02-05
| |
0.40
|
2020-12-23
| |
0.40
|
2020-12-07
| |
0.40
|
2020-11-06
| |
0.37
|
2020-10-07
| |
0.33
|
2020-09-08
| |
0.33
|
2020-08-07
| |
0.33
|
2020-07-08
| |
0.34
|
2020-06-05
| |
0.38
|
2020-05-07
| |
0.41
|
2020-04-07
| |
0.42
|
2020-03-06
| |
0.41
|
2020-02-07
| |
0.44
|
2019-12-26
| |
0.41
|
2019-12-06
| |
0.41
|
2019-11-07
| |
0.40
|
2019-10-07
| |
0.41
|
2019-09-09
| |
0.42
|
2019-08-07
| |
0.44
|
2019-07-08
| |
0.46
|
2019-06-07
| |
0.45
|
2019-05-07
| |
0.45
|
2019-04-05
| |
0.44
|
2019-03-07
| |
0.44
|
2019-02-07
| |
1.29
|
2018-12-24
| |
0.45
|
2018-12-07
| |
0.46
|
2018-11-07
| |
0.45
|
2018-10-05
| |
0.44
|
2018-09-10
| |
0.44
|
2018-08-07
| |
0.45
|
2018-07-09
| |
0.45
|
2018-06-07
| |
0.41
|
2018-05-07
| |
0.37
|
2018-04-06
| |
0.34
|
2018-03-07
| |
0.31
|
2018-02-07
| |
0.37
|
2017-12-28
| |
0.45
|
2017-12-07
| |
0.45
|
2017-11-07
| |
0.45
|
2017-10-06
| |
0.45
|
2017-09-08
| |
0.45
|
2017-08-07
| |
0.44
|
2017-07-10
| |
0.44
|
2017-06-07
| |
0.44
|
2017-05-05
| |
0.44
|
2017-04-07
| |
0.44
|
2017-03-07
| |
0.44
|
2017-02-07
| |
0.26
|
2016-12-29
| |
0.45
|
2016-12-07
| |
0.45
|
2016-11-07
| |
0.50
|
2016-10-07
| |
0.49
|
2016-09-08
| |
0.50
|
2016-08-05
| |
0.53
|
2016-07-08
| |
0.44
|
2016-06-07
| |
0.41
|
2016-05-06
| |
0.43
|
2016-04-07
| |
0.44
|
2016-03-07
| |
0.42
|
2016-02-05
| |
0.55
|
2015-12-31
| |
0.43
|
2015-12-07
| |
0.44
|
2015-11-06
| |
0.47
|
2015-10-07
| |
0.46
|
2015-09-08
| |
0.42
|
2015-08-07
| |
0.42
|
2015-07-08
| |
0.42
|
2015-06-05
| |
0.40
|
2015-05-07
| |
0.38
|
2015-04-08
| |
0.36
|
2015-03-06
| |
0.38
|
2015-02-06
| |
0.60
|
2014-12-31
| |
0.42
|
2014-12-05
| |
0.40
|
2014-11-07
| |
0.39
|
2014-10-07
| |
0.29
|
2014-09-08
| |
0.40
|
2014-08-07
| |
0.40
|
2014-07-08
| |
0.41
|
2014-06-06
| |
0.42
|
2014-05-07
| |
0.43
|
2014-04-07
| |
0.43
|
2014-03-07
| |
0.42
|
2014-02-07
| |
0.42
|
2014-01-02
| |
0.41
|
2013-12-06
| |
0.44
|
2013-11-07
| |
0.43
|
2013-10-07
| |
0.46
|
2013-09-09
| |
0.45
|
2013-08-07
| |
0.44
|
2013-07-08
| |
0.41
|
2013-06-07
| |
0.41
|
2013-05-07
| |
0.41
|
2013-04-05
| |
0.43
|
2013-03-07
| |
0.43
|
2013-02-07
| |
0.39
|
2013-01-02
| |
0.39
|
2012-12-07
| |
0.41
|
2012-11-07
| |
0.40
|
2012-10-05
| |
0.43
|
2012-09-10
| |
0.45
|
2012-08-07
| |
0.45
|
2012-07-09
| |
0.44
|
2012-06-07
| |
0.44
|
2012-05-07
| |
0.45
|
2012-04-09
| |
0.45
|
2012-03-07
| |
0.43
|
2012-02-07
| |
0.41
|
2012-01-04
| |
0.44
|
2011-12-07
| |
0.44
|
2011-11-07
| |
0.44
|
2011-10-07
| |
0.44
|
2011-09-08
| |
0.42
|
2011-08-05
| |
0.45
|
2011-07-08
| |
0.46
|
2011-06-07
| |
0.45
|
2011-05-06
| |
0.45
|
2011-04-07
| |
0.45
|
2011-03-07
| |
0.45
|
2011-02-07
| |
0.46
|
2011-01-04
| |
0.46
|
2010-12-07
| |
0.44
|
2010-11-05
| |
0.45
|
2010-10-07
| |
0.44
|
2010-09-08
| |
0.43
|
2010-08-06
| |
0.46
|
2010-07-08
| |
0.45
|
2010-06-07
| |
0.47
|
2010-05-07
| |
0.48
|
2010-04-08
| |
0.49
|
2010-03-05
| |
0.48
|
2010-02-05
| |
0.42
|
2010-01-05
| |
0.42
|
2009-12-07
| |
0.45
|
2009-11-06
| |
0.45
|
2009-10-07
| |
0.49
|
2009-09-08
| |
0.45
|
2009-08-07
| |
0.47
|
2009-07-08
| |
0.49
|
2009-06-05
| |
0.58
|
2009-05-07
| |
0.52
|
2009-04-07
| |
0.49
|
2009-03-06
| |
0.49
|
2009-02-06
| |
0.36
|
2009-01-02
| |
0.51
|
2008-12-05
| |
0.45
|
2008-11-07
| |
0.44
|
2008-10-07
| |
0.45
|
2008-09-08
| |
0.43
|
2008-08-07
| |
0.38
|
2008-07-08
| |
0.46
|
2008-06-06
| |
0.45
|
2008-05-07
| |
0.46
|
2008-04-07
| |
0.42
|
2008-03-07
| |
0.48
|
2008-02-07
| |
0.16
|
2007-12-27
|
